Thursday, August 21, 2008

Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed Contact Information

Read more here to obtain contact information for the facilities participating in the current clinical trial being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Locations:
U.T.M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Contact: Anne S. Tsao, MD
713-792-6363

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney

Mesothelioma & Asbestosis Mortalities Across the US: 1979-2001 (c/o EWG)

“We have seen first-hand how asbestos has wreaked havoc on Americans working in naval shipyards, automobile plants, and the construction industry. Most often this is through their employers’ conscious choice for profits over a worker's health.”

-- Joseph Patrick Williams, a trial attorney in the Asbestos Litigation department of Weitz & Luxenberg

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
	Mesothelioma Home Page
	Mesothelioma: An Overview
	The Clock Is Ticking
	Our Toughest Cases
	Diagnosis
	Symptoms, Stages, Treatment
	Latest News
	New York Numbers
	Asbestos
Mesothelioma Symptoms, Stages, Treatment of Mesothelioma Treatment Clinical trials on asbestos illness: mesothelioma IN THIS SECTION Imatinib Mesylate trial for mesothelioma patients Outcomes of Imatinib against mesothelioma cancer Recruitment data to test Imatinib on mesothelioma Inclusion standard in Imatinib mesothelioma trial Exclusion standard in Imatinib mesothelioma trial Contact info for Imatinib mesothelioma study

see also: Recruitment data to test Imatinib on mesothelioma Patient recruitment info for mesothelioma clinical trial with Imatinib Mesothelioma patient recruitment info for Imatinib therapy program Imatinib Mesylate trial for mesothelioma patients Clinical trial of Imatinib Mesylate therapy for mesothelioma patients Imatinib Mesylate may slow cancer cell growth in mesothelioma patients Current Imatinib therapy for mesothelioma patients Current clinical trial of Imatinib therapy for mesothelioma patients Imatinib may inhibit cancer cell growth in current mesothelioma test

Name	Phone	Email

Do you have a legal question? Ask us! strictly confidential

Your Question